- Recent Funding
- Investors
- Catalyze Capital
Catalyze Capital
Catalyze Capital has backed 1 company on Recent Funding, 1 in the last 12 months; its most recent deal is Breye Therapeutics (2026-09-29).
What Catalyze Capital invests in
- Health and bio · 1 · 100%
How Catalyze Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $67.5M |
Share is of the 1 round on Recent Funding that name Catalyze Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio
| Company | Round with Catalyze Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $67.5M | $67.5M | Sep 29, 2026 Series A |
Most frequent co-investors
IInnovestor1 shared round · last Sep 29, 2026
MMission BioCapital1 shared round · last Sep 29, 2026
NNovo Holdings1 shared round · last Sep 29, 2026
EExport and Investment Fund1 shared round · last Sep 29, 2026
- TThe Ljungstrom Family Office1 shared round · last Sep 29, 2026
SSound Bioventures1 shared round · last Sep 29, 2026
PPappas Capital1 shared round · last Sep 29, 2026
MModi Ventures1 shared round · last Sep 29, 2026
Portfolio companies are the companies on Recent Funding with a round that lists Catalyze Capital, which is a subset of its real portfolio. API: /api/v1/investors/catalyze-capital. All investors.
Catch them early
Stealth builders and new accelerator batches, weekly.
Unsubscribe anytime · privacy